1. Scoring rubric
Every provider on GLPOneReview.com is scored out of 100 across five weighted criteria. The thresholds are fixed before we evaluate any provider, and the same rubric is applied to every provider — including NexLife, our affiliated provider.
| Criterion | Weight | What we evaluate |
|---|---|---|
| Price Transparency | 25% | Are entry, maintenance, and total annual costs published clearly? Does pricing escalate by dose, by quantity, or by feature? Are HSA/FSA / insurance options disclosed? |
| Clinical Protocol | 25% | Type of clinician (MD/DO vs NP), intake format (video vs async vs AI-only), labs requirement, monitoring cadence, contraindication screening rigor. |
| Prescriber Access | 20% | Time to first response, ongoing message access, ability to escalate concerns, support hours, time to first prescription. |
| Patient Outcomes | 20% | Public Trustpilot & BBB ratings, average reported weight-loss results, retention metrics, complaint patterns. |
| Operational Transparency | 10% | Pharmacy disclosure (503A/503B), USP standards, third-party testing, certifications (LegitScript, NABP), state availability disclosure. |
2. Sources we use
- Tier 1 — Primary sources. Peer-reviewed clinical trials (PubMed-indexed), FDA prescribing information, USP general chapters, state pharmacy board records.
- Tier 2 — Provider self-reporting. Provider websites, terms of service, FAQ pages, patient-portal content, public press releases.
- Tier 3 — Third-party verification. LegitScript, NABP, Trustpilot, Better Business Bureau, public state regulatory records.
- Tier 4 — Editorial verification. Test patient signups (where ethically possible), email/chat response timing tests, patient-portal walkthroughs.
3. Pricing claim policy
Every pricing figure on this site is dated. We re-verify pricing on a monthly cadence and date the verification at the page level. If a price changes, we update the page within 72 hours of receiving documented evidence. We do not state "from $X" without disclosing whether that price is for the entry dose only, requires a 12-month commitment, or excludes shipping/labs/consult fees.
4. Conflict of interest disclosure
GLPOneReview.com is an independent editorial publication. This is the most material conflict of interest on the site, and we treat it as such:
- The affiliation is disclosed at the top of every page, in every footer, on the About page, on the Editorial Standards page, and again in NexLife-specific sections.
- The scoring rubric was published before our editorial assessment of NexLife's #1 position.
- We list NexLife's trade-offs (no brand-name access, cash-pay only, compounded medications not FDA-approved) prominently — not buried in fine print.
- We affirmatively recommend competing providers (Ro Body, Calibrate, Hims & Hers, Form Health) for patients whose needs NexLife does not fit.
5. What we do not do
- We do not accept paid placements, sponsored positions, or "review fee" payments to alter scoring.
- We do not allow advertisers to influence editorial content.
- We do not gate "best of" rankings to highest bidder.
- We do not publish reviews of providers we have not independently evaluated against the rubric.
6. Medical accuracy & review
Editorial content is medically reviewed by Adam Kennah, M.D., a board-certified independent physician reviewer. Dr. Kennah reviews dosing information, clinical-trial summaries, contraindication discussions, and pharmacy-quality content for accuracy before publication. He does not provide medical care to readers; he provides editorial review.
Research and writing is led by Dr. Parmis, medical researcher (Western University of Health Sciences).
7. Corrections policy
We respond to documented corrections within 72 hours. To submit a correction:
- Email glponereview@gmail.com with the URL of the page, the specific claim, and your evidence.
- If the claim is verifiable as inaccurate, we update the page and add a "Last corrected on [date]" note.
- If a provider believes our scoring is wrong, we re-run the rubric with the new evidence and publish the result.
8. Update cadence
Pricing and provider details are re-verified monthly. Clinical-evidence summaries are updated when major peer-reviewed trials publish (e.g., new SURMOUNT or STEP results). Regulatory content is updated when the FDA publishes new guidance.